Pharmaniaga's activity extends beyond manufacturing, encompassing logistics and distribution, as well as sales and marketing.
Pharmaniaga has over 3,522 employees, and more than 50 scientific and technical experts across various disciplines.
With five manufacturing plants, including one Indonesia plant, Pharmaniaga is capable of producing products in various forms; from oral solids, liquids and creams to small volume injectables. Its product portfolio encompasses a diverse segment of therapeutic areas such as cardiovascular, diabetes, anti-infectives, pain management, and respiratory, amongst others.
Its Indonesia operations comprise PT Errita Pharma (Errita) and PT Millennium Pharmacon International Tbk (MPI). MPI is a public listed company on the Indonesia Stock Exchange with 37 branches nationwide. Meanwhile, Errita produces over 60 generic pharmaceuticals as well as over-the-counter products.